CME Group Inc. $CME Shares Acquired by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. lifted its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 4.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 59,589 shares of the financial services provider’s stock after buying an additional 2,465 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in CME Group were worth $16,100,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Amundi grew its holdings in CME Group by 24.0% in the second quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after purchasing an additional 385,225 shares during the period. Alley Investment Management Company LLC raised its stake in CME Group by 86.0% during the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after purchasing an additional 13,512 shares during the period. Elevate Capital Advisors LLC boosted its holdings in shares of CME Group by 85.2% in the 3rd quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after purchasing an additional 3,919 shares during the last quarter. Victory Financial Group LLC grew its stake in shares of CME Group by 310.2% during the 2nd quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock valued at $839,000 after buying an additional 2,302 shares during the period. Finally, Chicago Capital LLC increased its holdings in shares of CME Group by 583.8% during the 3rd quarter. Chicago Capital LLC now owns 13,327 shares of the financial services provider’s stock worth $3,601,000 after buying an additional 11,378 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CME. Argus reduced their target price on CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Deutsche Bank Aktiengesellschaft raised their price objective on CME Group from $310.00 to $318.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Bank of America boosted their target price on CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Piper Sandler raised their price target on shares of CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Finally, Weiss Ratings reiterated a “buy (b+)” rating on shares of CME Group in a research note on Monday, December 29th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $292.18.

Check Out Our Latest Report on CME Group

CME Group Stock Up 0.5%

NASDAQ CME opened at $282.73 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a fifty-two week low of $232.32 and a fifty-two week high of $290.79. The business has a 50 day moving average price of $274.17 and a two-hundred day moving average price of $271.97. The stock has a market cap of $101.95 billion, a PE ratio of 27.40, a P/E/G ratio of 3.16 and a beta of 0.27.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The business had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.68 earnings per share. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Investors of record on Friday, December 12th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s payout ratio is 48.45%.

Insiders Place Their Bets

In related news, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the transaction, the director owned 1,091 shares in the company, valued at approximately $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 25,000 shares of the stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the transaction, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This represents a 27.53% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is currently owned by company insiders.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.